Skip to content

Effects of superficial wireless neuromodulation in healthy adults.

Effects of superficial wireless neuromodulation on wellness in healthy adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000263796
Enrollment
105
Registered
2022-02-14
Start date
2022-02-21
Completion date
2022-02-25
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is to assess the effects of the wireless superficial neuromodulation in quality of life and wellness or healthy people. Two sessions of 60 minutes duration will be applied and patients will fill general health, quality of life and wellness surveys before and 1 month after the intervention. We hypothesize that general health, quality of life and wellness levels will improve after treatment.

Interventions

Superficial Wireless Neuromodulation is a technique based on Bluetooth technology that consists of 4 wireless devices that are placed in the distal third of each of the extremities, controlled by an integrated application through a smartphone. This device emits biphasic and monophasic rectangular galvanic electrical impulses of very low frequency (0.5-14Hz) coordinated through 28 electrodes distributed between feet and hands (gloves and anklets). Patients will receive 2 sessions of Superficial

Superficial Wireless Neuromodulation is a technique based on Bluetooth technology that consists of 4 wireless devices that are placed in the distal third of each of the extremities, controlled by an integrated application through a smartphone. This device emits biphasic and monophasic rectangular galvanic electrical impulses of very low frequency (0.5-14Hz) coordinated through 28 electrodes distributed between feet and hands (gloves and anklets). Patients will receive 2 sessions of Superficial Wireless Neuromodulation, 60 minutes each session, held one week apart. The principal investigator and a trained researcher will apply the protocol and will register the attendance.

Sponsors

University of Deusto
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy volunteers

Exclusion criteria

None

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 8, 2026